Literature DB >> 21664790

If substance use disorder treatment more than offsets its costs, why don't more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration.

Keith Humphreys1, Todd H Wagner, Mistry Gage.   

Abstract

Given that many studies have reported that the costs of substance use disorder (SUD) treatment are more than offset by other savings (e.g., in health care, in criminal justice, in foster care), why haven't health care system managers rushed to expand treatment? This article attempts to explain this puzzling discrepancy by analyzing 1998-2006 data from the national Veterans Affairs (VA) health care system. The main outcome measures were annual cost and utilization for VA SUD-diagnosed patients. The key independent variable was the medical centers' annual spending for SUD treatment. There was no evidence that SUD spending was associated with lower medical center costs over time within the medical center that paid for the treatment. Health care system managers may not be influenced by research suggesting that the costs of SUD treatment are more than fully offset because they bear the cost of providing treatment while the savings largely accrue to other systems. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21664790     DOI: 10.1016/j.jsat.2011.04.006

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  10 in total

1.  Population-level cost-effectiveness of implementing evidence-based practices into routine care.

Authors:  John C Fortney; Jeffrey M Pyne; James F Burgess
Journal:  Health Serv Res       Date:  2014-10-18       Impact factor: 3.402

2.  Rethinking How We Measure Costs in Implementation Research.

Authors:  Todd H Wagner
Journal:  J Gen Intern Med       Date:  2020-10-26       Impact factor: 5.128

3.  Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence.

Authors:  Heide Jackson; Kara Mandell; Kimberly Johnson; Debanjana Chatterjee; David J Vanness
Journal:  Subst Abus       Date:  2015-03-16       Impact factor: 3.716

4.  Implementation and evaluation of the VA DPP clinical demonstration: protocol for a multi-site non-randomized hybrid effectiveness-implementation type III trial.

Authors:  Laura J Damschroder; Tannaz Moin; Santanu K Datta; Caitlin M Reardon; Nanette Steinle; Jane Weinreb; Charles J Billington; Matt L Maciejewski; William S Yancy; Maria Hughes; Fatima Makki; Caroline R Richardson
Journal:  Implement Sci       Date:  2015-05-12       Impact factor: 7.327

Review 5.  A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders.

Authors:  David R Gastfriend
Journal:  Ann N Y Acad Sci       Date:  2014-09-18       Impact factor: 5.691

6.  Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC.

Authors:  Hildi J Hagedorn; Randall Brown; Michael Dawes; Eric Dieperink; Donald Hugh Myrick; Elizabeth M Oliva; Todd H Wagner; Jennifer P Wisdom; Alex H S Harris
Journal:  Implement Sci       Date:  2016-05-10       Impact factor: 7.327

7.  Cost-effectiveness of the Adaptive Implementation of Effective Programs Trial (ADEPT): approaches to adopting implementation strategies.

Authors:  Andria B Eisman; David W Hutton; Lisa A Prosser; Shawna N Smith; Amy M Kilbourne
Journal:  Implement Sci       Date:  2020-12-14       Impact factor: 7.327

8.  Cost data in implementation science: categories and approaches to costing.

Authors:  Heather T Gold; Cara McDermott; Ties Hoomans; Todd H Wagner
Journal:  Implement Sci       Date:  2022-01-28       Impact factor: 7.327

9.  Directed funding to address under-provision of treatment for substance use disorders: a quantitative study.

Authors:  Austin B Frakt; Jodie Trafton; Amy Wallace; Matthew Neuman; Steven Pizer
Journal:  Implement Sci       Date:  2013-07-18       Impact factor: 7.327

10.  Assessment of the Medicare Advantage Risk Adjustment Model for Measuring Veterans Affairs Hospital Performance.

Authors:  Todd H Wagner; Peter Almenoff; Joseph Francis; Josephine Jacobs; Christine Pal Chee
Journal:  JAMA Netw Open       Date:  2018-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.